EGI
MDXG icon

EAM Global Investors’s MiMedx Group MDXG Stock Holding History

EAM Global Investors’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-163,606
Closed -$2.05M – 225
2021
Q2 		$2.05M Buy
+163,606
New +$1.77M 0.57% 105

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

EAM Global Investors's MDXG Position: Q3 2021 in Review

EAM Global Investors sold out of MiMedx Group (MDXG) in Q3 2021, closing a stake of 163,606 shares — an estimated $2.05M sold.

EAM Global Investors first reported a position in MDXG in Q2 2021 and held it in 1 quarter. The position peaked at $2.05M in Q2 2021. 142 funds tracked by Wall St. Rank hold MDXG as of Q3 2021.

  • EAM Global Investors reported no remaining MiMedx Group position as of Q3 2021 after selling out during the quarter.
  • EAM Global Investors sold 163,606 MiMedx Group shares in Q3 2021, an estimated $2.05M.
  • EAM Global Investors first reported a position in MiMedx Group in Q2 2021 and held it in 1 quarter.
  • EAM Global Investors's MiMedx Group position peaked at $2.05M in Q2 2021.
  • 142 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2021.

Based on EAM Global Investors's 13F filing for Q3 2021, filed 12 Nov 2021.